title: Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
abstract: Bisected, complex N-glycans on glycoproteins are generated by the glycosyltransferase MGAT3 and cause reduced cell surface binding of galectins. Previously, we showed that MGAT3 reduces growth factor signaling and retards mammary tumor progression driven by the Polyoma middle T antigen (PyMT) expressed in mammary epithelium under the mouse mammary tumor virus (MMTV) promoter. However, the penetrance of the tumor phenotype became variable in mixed FVB/N and C57BL/6 female mice and we therefore investigated a congenic C57BL/6 Mgat3(-/-)/MMTV-PyMT model. In the absence of MGAT3, C57BL/6 Mgat3(-/-)/MMTV-PyMT females exhibited accelerated tumor appearance and increased tumor burden, glucose uptake in tumors and lung metastasis. Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3. Activation of focal adhesion kinase (FAK), protein tyrosine kinase Src, and p38 mitogen-activated protein kinase were similar to that of controls. All the eight mouse galectin genes were expressed in mammary tumors and tumor epithelial cells (TECs), but galectin-2 and -12 were not detected by western analysis in tumors, and galectin-7 was not detected in 60% of the TEC lines. From microarray data reported for human breast cancers, at least 10 galectin and 7 N-glycan N-acetylglucosaminyl (GlcNAc)-transferase (MGAT) genes are expressed in tumor tissue, and expression often varies significantly between different breast cancer subtypes. Thus, in summary, while MGAT3 and bisected complex N-glycans retard mouse mammary tumor progression, genetic background may modify this effect; identification of key galectins that promote mammary tumor progression in mice is not straightforward because all the eight galectin genes are expressed; and high levels of MGAT3, galectin-4, -8, -10, -13 and -14 transcripts correlate with better relapse-free survival in human breast cancer.
authors.affiliation: Department of Cell Biology.
authors.forename: Hazuki E
authors.initials: HE
authors.lastname: Miwa
authors.forename: Wade R
authors.initials: WR
authors.lastname: Koba
authors.forename: Eugene J
authors.initials: EJ
authors.lastname: Fine
authors.forename: Orsi
authors.initials: O
authors.lastname: Giricz
authors.forename: Paraic A
authors.initials: PA
authors.lastname: Kenny
authors.forename: Pamela
authors.initials: P
authors.lastname: Stanley
mesh_terms: D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000378:metabolism; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D037161:Galectins / Q000378:metabolism*; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D008324:Mammary Tumor Virus, Mouse / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D017351:N-Acetylglucosaminyltransferases / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D011134:Polysaccharides / Q000378:metabolism*
chemical_list: D000952:Antigens, Polyomavirus Transforming; D037161:Galectins; D011134:Polysaccharides; D017351:N-Acetylglucosaminyltransferases; C054599:beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
keywords: MGAT3; TCGA; breast cancer; galectins; mammary tumors
references.citation: J Biol Chem. 2011 Sep 9;286(36):31320-7
references.pmid: 21757715
references.citation: Oncologist. 2005 Oct;10 Suppl 2:30-4
references.pmid: 16272457
references.citation: Clin Cancer Res. 2005 Apr 15;11(8):2962-8
references.pmid: 15837748
references.citation: Mol Cancer Res. 2004 Nov;2(11):632-42
references.pmid: 15561779
references.citation: Breast Cancer Res Treat. 2010 Oct;123(3):725-31
references.pmid: 20020197
references.citation: Lancet. 2005 Feb 19-25;365(9460):671-9
references.pmid: 15721472
references.citation: FEBS Lett. 2008 Apr 16;582(9):1362-8
references.pmid: 18371311
references.citation: J Cell Biol. 2005 Oct 24;171(2):373-81
references.pmid: 16247033
references.citation: J Gen Physiol. 1927 Mar 7;8(6):519-30
references.pmid: 19872213
references.citation: Cell. 1975 Oct;6(2):121-8
references.pmid: 1182798
references.citation: J Cell Sci. 1995 Dec;108 ( Pt 12):3735-43
references.pmid: 8719880
references.citation: Biochemistry. 2011 Sep 20;50(37):7842-57
references.pmid: 21848324
references.citation: BMC Bioinformatics. 2011 Dec 15;12:474
references.pmid: 22172014
references.citation: Science. 2004 Oct 1;306(5693):120-4
references.pmid: 15459394
references.citation: Curr Opin Cell Biol. 2011 Aug;23(4):383-92
references.pmid: 21616652
references.citation: Traffic. 2009 Nov;10(11):1569-78
references.pmid: 19761541
references.citation: Cancer Res. 2013 Feb 1;73(3):1107-17
references.pmid: 23204230
references.citation: Nat Rev Cancer. 2004 Nov;4(11):891-9
references.pmid: 15516961
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15975-80
references.pmid: 17043243
references.citation: Cell. 2013 May 9;153(4):910-8
references.pmid: 23643243
references.citation: Nature. 2012 Oct 4;490(7418):61-70
references.pmid: 23000897
references.citation: Genetics. 2008 Mar;178(3):1533-45
references.pmid: 18385114
references.citation: Glycoconj J. 2004;19(7-9):433-40
references.pmid: 14758066
references.citation: Glycobiology. 2006 Apr;16(4):305-17
references.pmid: 16319083
references.citation: Cell. 2005 Dec 29;123(7):1307-21
references.pmid: 16377570
references.citation: PLoS One. 2011;6(8):e23205
references.pmid: 21826239
references.citation: Nucleic Acids Res. 2012 Aug;40(15):e115
references.pmid: 22730293
references.citation: Mol Cell Proteomics. 2013 Apr;12(4):913-20
references.pmid: 23378517
references.citation: Nat Rev Cancer. 2009 Apr;9(4):239-52
references.pmid: 19279573
references.citation: Cancer Res. 2010 Aug 1;70(15):6216-24
references.pmid: 20647324
references.citation: PLoS One. 2012;7(6):e39646
references.pmid: 22737251
references.citation: Transgenic Res. 2007 Apr;16(2):193-201
references.pmid: 17206489
references.citation: J Histochem Cytochem. 2009 Jan;57(1):41-50
references.pmid: 18796404
references.citation: Glycoconj J. 2012 Dec;29(8-9):609-18
references.pmid: 22476631
references.citation: Cancer Res. 2011 Jul 1;71(13):4423-31
references.pmid: 21546572
references.citation: J Exp Med. 2012 Oct 22;209(11):1985-2000
references.pmid: 23027923
references.citation: Glycobiology. 2008 Oct;18(10):750-60
references.pmid: 18701722
references.citation: J Biol Chem. 2004 Mar 19;279(12):10841-7
references.pmid: 14672941
references.citation: Curr Opin Struct Biol. 2002 Oct;12(5):616-23
references.pmid: 12464313
references.citation: Cell. 2007 Apr 6;129(1):123-34
references.pmid: 17418791
references.citation: J Biol Chem. 2010 Feb 19;285(8):5759-75
references.pmid: 19951948
references.citation: Glycobiology. 2008 Sep;18(9):735-44
references.pmid: 18579572
references.citation: Glycobiology. 1997 Feb;7(1):45-56
references.pmid: 9061364
references.citation: Eur J Biochem. 2004 Jan;271(1):118-34
references.pmid: 14686925
references.citation: Glycobiology. 2009 Jan;19(1):68-75
references.pmid: 18849326
references.citation: Mol Cell Biol. 1992 Mar;12(3):954-61
references.pmid: 1312220
references.citation: J Biol Chem. 2004 Dec 3;279(49):51630-46
references.pmid: 15355971
references.citation: N Engl J Med. 2002 Dec 19;347(25):1999-2009
references.pmid: 12490681
references.citation: Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18696-701
references.pmid: 21969596
references.citation: J Biol Chem. 2012 Jul 20;287(30):24941-54
references.pmid: 22665489
references.citation: J Clin Invest. 2005 May;115(5):1163-76
references.pmid: 15841211
references.citation: Biochemistry. 1983 Jul 19;22(15):3671-80
references.pmid: 6615790
references.citation: Cell. 2012 Apr 27;149(3):656-70
references.pmid: 22541435
references.citation: J Biol Chem. 1984 Nov 10;259(21):13370-8
references.pmid: 6238035
references.citation: Biochemistry. 2007 Jun 12;46(23):6984-95
references.pmid: 17497937
references.citation: Cancer Res. 2010 Apr 15;70(8):3361-71
references.pmid: 20395209
references.citation: Bioinformatics. 2007 May 15;23(10):1289-91
references.pmid: 17379693
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2995-3000
references.pmid: 20133630
references.citation: Clin Cancer Res. 2009 May 15;15(10):3265-76
references.pmid: 19447867